Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2008
11/27/2008CA2684920A1 Methods of treating cognitive disorders by inhibition of gpr12
11/27/2008CA2684885A1 Preparative purification process for human furin
11/27/2008CA2684879A1 Methods of identifying genes involved in memory formation using small interfering rna (sirna)
11/27/2008CA2681878A1 Genes encoding z,z-farnesyl diphosphate synthase and a sesquiterpene synthase with multiple products and uses thereof
11/27/2008CA2680661A1 Mutant reoviruses and methods of making and using
11/27/2008CA2676028A1 Methods of determining lethality of pathogens and malignancies involving replikin peak genes
11/27/2008CA2671934A1 Plant-made west nile virus (wnv) vaccines, vectors and plant codon optimized sequences
11/26/2008EP1995330A1 Modified oligonucleotides for mismatch discrimination
11/26/2008EP1995326A1 Two stage methods for examining nucleic acid by using one and the same sample
11/26/2008EP1995321A2 Gene disruptions, compositions and methods relating thereto
11/26/2008EP1995320A2 Polynucleotide markers
11/26/2008EP1995319A1 Bacillus licheniformis mutant host cell
11/26/2008EP1995318A1 Mammalian cell surface antigens; related reagents
11/26/2008EP1995317A1 Mammalian cell surface antigens; related reagents
11/26/2008EP1995316A1 Method for gentle purification of cells, cell production and cell transfection
11/26/2008EP1995315A2 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
11/26/2008EP1995314A1 Method for production of erythro- or threo-2-amino-3-hydroxypropionic acid ester, novel carbonyl reductase, gene for the reductase, vector, transformant, and method for production of optically active alcohol using those
11/26/2008EP1995312A1 Alg3 mutant
11/26/2008EP1995311A1 Rice peroxidases with various characteristics
11/26/2008EP1995310A1 Novel methods for rescue of RNA viruses
11/26/2008EP1995308A1 Bacterium capable of producing organic acid, and method for production of organic acid
11/26/2008EP1995306A1 Novel microbe, lipid modifying agent, process for producing 2-acyl-lysophospholipid, process for producing diacylglycerol, process for producing ceramide, and method of degumming oil or fat
11/26/2008EP1995303A2 Enzyme preparation with endoglucanase activity
11/26/2008EP1995256A1 EPHA2 T-cell epitope agonists and uses therefor
11/26/2008EP1995255A1 Truncated tau proteins
11/26/2008EP1994942A1 Pharmaceutical compositions comprising telomerase, and uses thereof
11/26/2008EP1994937A2 Prevention and treatment of amyloidogenic disease
11/26/2008EP1994824A1 Chimeric non-human animal
11/26/2008EP1994408A2 Proteomic fingerprinting of human ivf-derived embryos: identification of biomarkers of developmental potential
11/26/2008EP1994178A2 Detection of molecular interactions using a reduced affinity enzyme complementation reporter system
11/26/2008EP1994176A2 Methods and agents for modulating an immune response
11/26/2008EP1994175A1 Solution pre-treatment for use in dna amplification reactions
11/26/2008EP1994165A2 Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine
11/26/2008EP1994164A2 Specific amplification of fetal dna sequences from a mixed, fetal-maternal source
11/26/2008EP1994159A1 Use of recombinant modified vaccinia virus ankara (mva) for the treatment of type 1 hypersensitivity in a living animal including humans
11/26/2008EP1994158A2 Epsp synthase enzyme domains conferring glyphosate resistance
11/26/2008EP1994157A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
11/26/2008EP1994156A1 Chimeric tymovirus-like particles
11/26/2008EP1994154A2 Modulating alkaloid biosynthesis
11/26/2008EP1994153A2 Chimeric kunitz domains and their use
11/26/2008EP1994152A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/26/2008EP1994151A2 Compositions and methods for detection and treatment of human herpesvirus (hhv)-6
11/26/2008EP1994150A1 Method for identifying useful proteins of brewery yeast
11/26/2008EP1994149A2 Novel fluorescent proteins and methods for using same
11/26/2008EP1994148A1 Polypeptides having endoglucanase activity and polynucleotides encoding same
11/26/2008EP1994147A1 Use of a thermostable phospholipase in the degumming of an oil or fat, and a method for obtaining a thermostable phospholipase
11/26/2008EP1994145A2 Production of biologically active proteins
11/26/2008EP1994142A2 Methods and compositions for the rapid isolation of small rna molecules
11/26/2008EP1994138A2 Process for preparing human g-csf
11/26/2008EP1994053A1 Soluble gp130 molecule variants useful as a medicament
11/26/2008EP1994050A1 Gene encoding transcriptional inducer for maltase gene and maltose transporter gene and use thereof
11/26/2008EP1994049A1 Gene encoding acetolactate synthase and use thereof
11/26/2008EP1993672A2 Na/k-atpase ligand
11/26/2008EP1993611A2 RNAi MODULATION OF TGF-BETA AND THERAPEUTIC USES THEREOF
11/26/2008EP1993597A2 Human telomerase reverse transcriptase peptides
11/26/2008EP1993584A2 Compositions and methods for the treatment of ophthalmic disease
11/26/2008EP1993349A2 Soybean seed and oil compositions and methods of making same
11/26/2008EP1869193B1 Reconstructed human mariner transposon capable of stable gene transfer into chromosomes in vertebrates
11/26/2008EP1863334A4 Drought-resistant plants
11/26/2008EP1841783A4 Second tc complex from xenorhabdus
11/26/2008EP1802753A4 Method for storing dna by using chitosan, and products using the methods
11/26/2008EP1699289B1 Non-human mammal comprising a modified serca2 gene and methods, cells, genes, and vectors thereof
11/26/2008EP1673388B1 Cxcl8 antagonists
11/26/2008EP1527172B1 Method for nucleic acid extraction and nucleic acid purification
11/26/2008EP1521770B1 Method for the production of protamine
11/26/2008EP1515752B1 Ace2 activation for treatment of heart, lung and kidney disease and hypertension
11/26/2008EP1493035B1 Method for selecting bioactive agents by detecting variation induced in cyclic amp intracellular concentration of a sensitive living cell
11/26/2008EP1434592B1 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
11/26/2008EP1419173B1 Peptides that bind to atherosclerotic lesions
11/26/2008EP1417346B1 Method for identifying macrocyclic polyketides
11/26/2008EP1404836B1 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
11/26/2008EP1396539B1 Human-type anti-blood coagulation factor viii antibody
11/26/2008EP1366187B1 Oligonucleotides for labeling oligonucleotide probes and proteins
11/26/2008EP1322782B1 Method of nucleic acid typing or sequencing
11/26/2008EP1309730B1 New hydrazide building blocks and hydrazide modified biomolecules
11/26/2008EP1307478B1 Luxr gene from coryneform bacteria and a process for the production of l-amino acids
11/26/2008EP1298988B1 Transgenic mouse for screening and for studies of the pharmacodynamics and pharmacokinetics of ligands acting on intracellular receptors, and method for the preparation thereof
11/26/2008EP1287145B1 The non-mevalonate isoprenoid pathway
11/26/2008EP1257642B1 Partners of ptb1 domain of fe65, preparation and uses
11/26/2008EP1245672B1 Method of screening candidate for artificial promoter
11/26/2008EP1124953B1 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
11/26/2008EP1108042B1 Molecules designated b7l-1
11/26/2008EP1104231B1 Biodegradable high oxidative stability oils
11/26/2008EP1019537B1 Bioassay for thyroid stimulating antibodies
11/26/2008EP0969875B1 Naked dna-mediated gene transfer into medullary motor neurons
11/26/2008EP0865293B1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling
11/26/2008EP0821732B1 Altered polypeptides with increased half-life
11/26/2008EP0820463B1 Igf-i purification process
11/26/2008CN101313072A Cell nuclear transfer
11/26/2008CN101313071A Transgenic aloe plants for production of proteins and related methods
11/26/2008CN101313070A Low acrylamide foods
11/26/2008CN101313069A Bioassays
11/26/2008CN101313068A Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
11/26/2008CN101313067A DNA constructs for specific inhibition of gene expression by RNA interference
11/26/2008CN101313066A Modulation of glucocorticoid receptor expression
11/26/2008CN101313065A Production of reprogrammed cells with restored potential
11/26/2008CN101313064A 基因扩增方法 Gene amplification method
11/26/2008CN101313063A Cancer-rejection antigen peptide derived from glypican-3 (GPC3) for use in HLA-A2-positive patient and pharmaceutical comprising the antigen
11/26/2008CN101312745A Therapeutic agent for skin or skin repair-promoting agent comprising ghrelin, derivative thereof or substance capable of acting on ghs-r1a as active ingredient
11/26/2008CN101312740A Wwox gene, vectors containing the same, and uses in treatment of cancer
1 ... 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 ... 4023